Archives: Agenda

Navigating Clinical Operations in Biotech’s Survival Mode 生物医药寒冬之下：如何驾驭临床运营的“生存模式”

  • Building Cross-Functional Leadership: Developing “T-shaped” talent with end-to-end operational vision.
  • Proactive Risk Management: Systematically anticipating and mitigating clinical trial risks.
  • Strategic Partnership with CROs: Redefining sponsor-CRO collaboration beyond transactional outsourcing.
  • From Trial Data to Market Value: Making clinical quality the cornerstone of biotech IPO credibility.

 

  • 构建跨职能领导力： 培养具备端到端（全流程）运营视野的“T型”复合型人才。
  • 前瞻性风险管理： 系统性地预测并缓解临床试验过程中的潜在风险。
  • 与 CRO 的战略合作伙伴关系： 重新定义申办方与 CRO 的合作模式，摆脱单纯的“交易型外包“。
  • 从试验数据到市场价值： 让临床质量成为生物医药企业 IPO（上市）公信力的基石。

Why Patients Walk Away from Clinical Trials and What the Industry Still Gets Wrong

  • Understanding why patients decline or leave clinical trials beyond the reasons captured in trial data
  • Exploring how trial design and patient burden can create barriers to participation
  • Examining how sponsors and sites can build trust and better support patients
  • Sharing practical ways to improve recruitment, retention and the overall patient experience